She died after a long battle with illness. British rising star Faye Fantarrow died at her home on August 26 at the age of 21. It was his mother who announced the death on X (formerly Twitter) on Thursday. The young woman suffered from an aggressive and rare brain tumor since last year, reports the BBC, which has accompanied the singer since her beginnings in music.
The young singer, who had just released her first EP this year, “had a wisdom, compassion and understanding that went beyond her years,” her mother wrote in the message posted on social networks. Her daughter “loved fiercely, laughed easily and lived gregariously,” she continues by way of tribute. The artist from Sunderland, England, had already had to deal with illness. As a child, she developed leukemia twice.
Faye Fantarrow had just released her first EP in 2023. She had launched into music four years earlier with a first title, Lines, which made her known in her country. The young woman had been spotted for her talent by BBC Music Introducing, a branch of Anglo-Saxon radio intended to discover emerging artists, which had qualified her as an “artist to watch”.
Faye Fantarrow was very supported by Dave Stewart, the singer of the group Eurythmics, who had signed her via his label, Bay Street Records. “Words fail me to express how devastated I was when, just after spending some amazing creative time with Faye last summer making her debut album, Faye was told she had a brain tumor. very aggressive,” he said in a statement. He remembers an artist he “deeply loved” and working alongside her, an experience he “will never forget”.
Since the announcement of her illness, Faye Fantarrow had collected nearly 275,000 euros via fundraising to finance an experimental treatment for her illness. She was hospitalized in California, where research on this rare pathology is still in its infancy. Having become too weak to go back and forth between her native England and the United States, she insisted that the remaining money be donated to associations for the fight against cancer.
